UBS Group
SILO icon

UBS Group’s Silo Pharma SILO Stock Holding History

UBS Group’s Portfolio SILO Stock Details SILO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-403
Closed -$2.05K – 11101
2025
Q4 		$2.05K Sell
403
-196
-33% -$1.45K ﹤0.01% 9392
2025
Q3 		$6.2K Buy
+599
New +$5.99K ﹤0.01% 8796
2025
Q1 		– Sell
-1,339
Closed -$17.9K – 10678
2024
Q4 		$17.9K Buy
+1,339
New +$20.7K ﹤0.01% 7949
2024
Q2 		– Sell
-25
Closed -$729 – 10029
2024
Q1 		$729 Sell
25
-2,165
-99% -$51.5K ﹤0.01% 8388
2023
Q4 		$47.3K Buy
+2,190
New +$49.6K ﹤0.01% 6564
2023
Q1 		– Sell
-347
Closed -$17.5K – 10295
2022
Q4 		$17.5K Sell
347
-106
-23% -$6.2K ﹤0.01% 7827
2022
Q3 		$37K Buy
+453
New +$34.9K ﹤0.01% 6639

Other funds holding SILO

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group's SILO Position: Q1 2026 in Review

UBS Group sold out of Silo Pharma (SILO) in Q1 2026, closing a stake of 403 shares — an estimated $2.05K sold.

UBS Group first reported a position in SILO in Q3 2022 and held it in 7 quarters. The position peaked at $47.3K in Q4 2023. 14 funds tracked by Wall St. Rank hold SILO as of Q1 2026.

  • UBS Group reported no remaining Silo Pharma position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 403 Silo Pharma shares in Q1 2026, an estimated $2.05K.
  • UBS Group first reported a position in Silo Pharma in Q3 2022 and held it in 7 quarters.
  • UBS Group's Silo Pharma position peaked at $47.3K in Q4 2023.
  • 14 funds tracked by Wall St. Rank held Silo Pharma as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.